The FDA has cracked down on the use of power morcellators in recent years. The devices are used in gynecological and general laparoscopic procedures to break up uterine fibroids and other tissue ...
The "Short-read Transpore Rapid Karyotyping," or "STORK" for short, is an inexpensive rapid test created by Columbia University researchers that is able to accurately detect genetic disorders in a ...
Live Science on MSN
New tests could nearly halve the rate of late-stage cancers, some scientists say — is that true?
The study suggests the tests could save lives by catching cancer at earlier stages, when it's more easily treated. It predicted that, over a decade of use, MCEDs could reduce stage IV cancer diagnoses ...
Labcorp Oncology, Director, Medical Affairs and Adjunct Assistant Professor, Duke University Medical Center, Duke Cancer Institute, Department of Obstetrics & Gynecology, Division of Gynecologic ...
Animal testing could slowly be replaced with experiments using artificial tissue thanks to groundbreaking work using lasers done by the Vienna Technical University (TU Wien) in Austria. The idea ...
Integrating the business of oncology during oncology fellowship: An ASCO State of Cancer Care in America (SOCCA) study of professional preparedness and practice expectations among medical oncology ...
The blood test also had a sensitivity and specificity of 92.3% and 92.6% for participants who do not have breast cancer. The results were consistent for women with dense breast tissue and non-dense ...
LifeNet Health, a global leader in regenerative medicine, has acquired Tissue Testing Technologies LLC (T3), a biotechnology company specializing in biopreservation. T3 's advanced proprietary ...
At TU Wien, researchers are developing three-dimensional (3D) printing techniques that can be used to create living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results